
Jared Barsky
Examiner (ID: 17064)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1106 |
| Issued Applications | 489 |
| Pending Applications | 147 |
| Abandoned Applications | 499 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19202742
[patent_doc_number] => 20240174641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING
[patent_app_type] => utility
[patent_app_number] => 18/493126
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493126
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/493126 | HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING | Oct 23, 2023 | Pending |
Array
(
[id] => 19032394
[patent_doc_number] => 20240082209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PAIN WITH WOGONIN
[patent_app_type] => utility
[patent_app_number] => 18/491644
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491644 | Compositions and methods for treating pain with wogonin | Oct 19, 2023 | Issued |
Array
(
[id] => 20561992
[patent_doc_number] => 12564582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Use of pridopidine for treating dystonias
[patent_app_type] => utility
[patent_app_number] => 18/489846
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 64
[patent_no_of_words] => 15042
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18489846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/489846 | Use of pridopidine for treating dystonias | Oct 18, 2023 | Issued |
Array
(
[id] => 19003578
[patent_doc_number] => 20240067649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => NLRP3 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/488092
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18488092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/488092 | NLRP3 modulators | Oct 16, 2023 | Issued |
Array
(
[id] => 18987680
[patent_doc_number] => 20240059649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/488215
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18488215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/488215 | SUBSTITUTED N-ACETYL-L-CYSTEINE DERIVATIVES AND RELATED COMPOUNDS | Oct 16, 2023 | Pending |
Array
(
[id] => 19170796
[patent_doc_number] => 20240156770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/488616
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18488616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/488616 | HIGH PENETRATION PRODRUG COMPOSITIONS OF RETINOIDS AND RETINOID-RELATED COMPOUNDS | Oct 16, 2023 | Abandoned |
Array
(
[id] => 18971844
[patent_doc_number] => 20240051936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => ISOINDOLINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/485766
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18485766
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/485766 | ISOINDOLINONE COMPOUNDS | Oct 11, 2023 | Pending |
Array
(
[id] => 19081199
[patent_doc_number] => 20240108000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => DISINFECTANT COMPOSITIONS EXHIBITING ENHANCED BIOCIDAL BENEFITS
[patent_app_type] => utility
[patent_app_number] => 18/478097
[patent_app_country] => US
[patent_app_date] => 2023-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18478097
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/478097 | DISINFECTANT COMPOSITIONS EXHIBITING ENHANCED BIOCIDAL BENEFITS | Sep 28, 2023 | Abandoned |
Array
(
[id] => 18860087
[patent_doc_number] => 20230414521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/367416
[patent_app_country] => US
[patent_app_date] => 2023-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18367416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/367416 | SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME | Sep 11, 2023 | Pending |
Array
(
[id] => 18986350
[patent_doc_number] => 20240058319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Methods of Treating Ovarian Cancer
[patent_app_type] => utility
[patent_app_number] => 18/463851
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18463851
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/463851 | Methods of treating ovarian cancer | Sep 7, 2023 | Issued |
Array
(
[id] => 18948072
[patent_doc_number] => 11891353
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-02-06
[patent_title] => 3,3'-(hydrazine-1,2-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as an ecofriendly insecticidal agent against
[patent_app_type] => utility
[patent_app_number] => 18/238694
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2965
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238694
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/238694 | 3,3'-(hydrazine-1,2-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as an ecofriendly insecticidal agent against | Aug 27, 2023 | Issued |
Array
(
[id] => 18842551
[patent_doc_number] => 20230404955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION
[patent_app_type] => utility
[patent_app_number] => 18/455813
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455813
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455813 | USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION | Aug 24, 2023 | Abandoned |
Array
(
[id] => 18893654
[patent_doc_number] => 20240009139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => STABLE WOUND CARE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/228476
[patent_app_country] => US
[patent_app_date] => 2023-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18228476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/228476 | STABLE WOUND CARE FORMULATION | Jul 30, 2023 | Abandoned |
Array
(
[id] => 20715315
[patent_doc_number] => 12630549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-19
[patent_title] => Pyrazoleamide derivatives
[patent_app_type] => utility
[patent_app_number] => 18/361526
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361526 | PYRAZOLEAMIDE DERIVATIVES | Jul 27, 2023 | Issued |
Array
(
[id] => 18953465
[patent_doc_number] => 20240041792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => TOPICAL COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/359199
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18359199
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/359199 | TOPICAL COMPOSITIONS AND USES THEREOF | Jul 25, 2023 | Pending |
Array
(
[id] => 18836724
[patent_doc_number] => 11844781
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-19
[patent_title] => Polymeric clotrimazole biofilm for the treatment of otomycosis
[patent_app_type] => utility
[patent_app_number] => 18/221183
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1205
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18221183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/221183 | Polymeric clotrimazole biofilm for the treatment of otomycosis | Jul 11, 2023 | Issued |
Array
(
[id] => 18815934
[patent_doc_number] => 20230390273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => 4-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR TREATING HEARING DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/347041
[patent_app_country] => US
[patent_app_date] => 2023-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18347041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/347041 | 4-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR TREATING HEARING DISEASES | Jul 4, 2023 | Pending |
Array
(
[id] => 19034084
[patent_doc_number] => 20240083899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => PURINONE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/217817
[patent_app_country] => US
[patent_app_date] => 2023-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18217817
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/217817 | PURINONE DERIVATIVE | Jul 2, 2023 | Abandoned |
Array
(
[id] => 18860124
[patent_doc_number] => 20230414558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN ALLEVIATION OF RADIATION-INDUCED SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/342313
[patent_app_country] => US
[patent_app_date] => 2023-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18342313
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/342313 | PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN ALLEVIATION OF RADIATION-INDUCED SKIN DISORDERS | Jun 26, 2023 | Pending |
Array
(
[id] => 18860117
[patent_doc_number] => 20230414551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TOPICAL FORMULATIONS OF NITROGLYCERIN
[patent_app_type] => utility
[patent_app_number] => 18/215058
[patent_app_country] => US
[patent_app_date] => 2023-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215058
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215058 | Topical formulations of nitroglycerin | Jun 26, 2023 | Issued |